Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18656137 | 0.84 | MAPT (0.35) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL24934193 | 0.81 | SMN1; SMN2 (0.40) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL8281296 | 0.77 | PARP1 (0.44) | SMN1; SMN2KDM4EHPGDHDAC8TDP1 | |
| SCHEMBL10775625 | 0.74 | SMN1; SMN2 (0.48) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL16939757 | 0.72 | MAPT (0.43) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL12759570 | 0.72 | CASP3 (0.43) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL16939761 | 0.72 | CASP3 (0.43) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL299924 | 0.71 | MAPT (0.46) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL31529664 | 0.71 | MAPT (0.46) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 | |
| SCHEMBL2737366 | 0.71 | RXRA (0.51) | MAPTSMN1; SMN2ALDH1A1KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250106-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250106-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | STING1, CGAS, IRF3 | MAPT 3027/4885SMN1; SMN2 2298/4885ALDH1A1 4654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.